Loading company…
Transbiomed develops diagnostic technology for prostate cancer.
Transbiomed is a biotechnology company that developed a urine test for early diagnosis of prostate cancer. It intends to begin clinical validation in Spanish hospitals. Founded in 2007, the company is based in Barcelona, Spain, and is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in